Heres what research tells us so far: Studies including over 1,000 women exposed to GLP-1s during the first trimester have not shown an increased chance of birth defects
Texila International Journal of Basic Medical Science, Vol 2 (1), Issue 1, Jul 2017, 1-22
To maximize therapeutic benefit, healthcare providers should closely monitor treatment adherence and ensure patients are well informed about the potential rebound in cardiometabolic risk following treatment discontinuation
Steady adherence reveals your genuine appetite suppression, satiety response, and side effect profileall critical data for personalized precision therapy
Important Compliance and Handling Please note that KLOW 80MG is not intended for human or veterinary use
Consistency in timing and following fasting instructions is crucial to ensure the medication is effectively absorbed